XML 54 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
12 Months Ended
Mar. 31, 2025
Class Of Stock [Line Items]  
Summary of Stock Option Activity

The following table summarizes stock option activity for the year ended March 31, 2025:

 

 

 

Options
Outstanding

 

 

Weighted-
Average
Exercise Price

 

 

Aggregate
Intrinsic
Value

 

Outstanding at March 31, 2024

 

 

58,140

 

 

$

51.14

 

 

$

 

Options granted

 

 

96,169

 

 

$

7.11

 

 

$

 

Options canceled

 

 

(12,912

)

 

$

35.08

 

 

$

 

Outstanding at March 31, 2025

 

 

141,397

 

 

$

22.66

 

 

$

 

Vested and Exercisable at March 31, 2025

 

 

40,292

 

 

$

57.61

 

 

$

 

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following at March 31, 2025:

 

Common stock issuable pursuant to options outstanding and reserved under the 2012 Plan

 

 

31,292

 

Common stock reserved under the 2012 Plan

 

 

 

Common stock issuable pursuant to options outstanding and reserved under the A&R 2022 Plan

 

 

105,939

 

Common stock reserved under the A&R 2022 Plan

 

 

198,774

 

Common stock reserved under the ESPP

 

 

3,708

 

Common stock reserved under the 2021 Inducement Equity Plan

 

 

83

 

Common stock issuable pursuant to restricted stock units outstanding under the 2012 Plan

 

 

 

Common stock issuable pursuant to restricted stock units outstanding under the A&R 2022 Plan

 

 

8,165

 

Common stock issuable pursuant to options outstanding and reserved under the Inducement Plan

 

 

4,166

 

Common stock issuable pursuant to outstanding Pre-Funded Warrants

 

 

 

Common stock issuable pursuant to outstanding Common Warrants

 

 

539,060

 

Total at March 31, 2025

 

 

891,187

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense for all stock-based awards consists of the following (in thousands):

 

 

 

Year Ended
March 31, 2025

 

 

Year Ended
March 31, 2024

 

Research and development

 

$

86

 

 

$

138

 

General and administrative

 

 

446

 

 

 

1,370

 

Total

 

$

532

 

 

$

1,508

 

Fair Value of Employee Stock Options The fair value of stock options was estimated at the grant date using the following weighted average assumptions:

 

 

 

Year Ended
March 31, 2025

 

 

Year Ended
March 31, 2024

 

Dividend yield

 

 

 

 

 

 

Volatility

 

 

99.38

%

 

 

99.04

%

Risk-free interest rate

 

 

3.75

%

 

 

4.11

%

Expected life of options

 

5.75 years

 

 

6 years

 

Weighted average grant date fair value

 

$

5.67

 

 

$

1.34

 

Summary of Warrant Activity

The following table summarizes the Company’s Common Warrant activity from March 31, 2024 to March 31, 2025:

 

 

 

Number of Warrants

 

Exercise Price

Outstanding at March 31, 2024

 

 

Issued

 

546,870

 

$9.60

Exercised

 

(7,810)

 

$9.60

Outstanding at March 31, 2025

 

539,060

 

$9.60

The following table summarizes the Company’s Pre-Funded Warrants activity from March 31, 2024 to March 31, 2025:

 

 

 

Number of Warrants

 

 

Exercise Price

 

Outstanding at March 31, 2024

 

 

 

 

 

 

Issued

 

 

416,666

 

 

$

0.001

 

Exercised

 

 

(416,666

)

 

$

0.001

 

Outstanding at March 31, 2025

 

 

 

 

 

 

Restricted stock units (RSUs) [Member]  
Class Of Stock [Line Items]  
Summary of Company's RSUs Activity

The following table summarizes the Company’s RSUs activity for the year ended March 31, 2025:

 

 

 

Number of
Shares

 

 

Weighted
Average Price

 

Unvested at March 31, 2024

 

 

10,214

 

 

$

21.02

 

Granted

 

 

9,798

 

 

$

6.57

 

Vested

 

 

(10,214

)

 

$

21.02

 

Cancelled / forfeited

 

 

(1,633

)

 

$

6.57

 

Unvested at March 31, 2025

 

 

8,165

 

 

$

6.57

 

ESPP Shares [Member]  
Class Of Stock [Line Items]  
Fair Value of Employee Stock Options The fair value of the ESPP shares was estimated at the purchase period commencement date using the following assumptions:

 

 

 

Year Ended
March 31, 2025

 

 

Year Ended
March 31, 2024

 

Dividend yield

 

 

 

 

 

 

Volatility

 

 

95.20

%

 

 

95.20

%

Risk-free interest rate

 

 

5.27

%

 

 

5.27

%

Expected term

 

6 months

 

 

6 months

 

Grant date fair value

 

$

0.39

 

 

$

0.39